Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 179

1.

Comparing Pretransplant and Posttransplant Outcomes When Choosing a Transplant Center: Focus Groups and a Randomized Survey.

Schaffhausen CR, Bruin MJ, Chu S, Wey A, McKinney WT, Snyder JJ, Lake JR, Matas AJ, Kasiske BL, Israni AK.

Transplantation. 2019 Jun 24. doi: 10.1097/TP.0000000000002809. [Epub ahead of print]

PMID:
31283676
2.

Tacrolimus troughs and genetic determinants of metabolism in kidney transplant recipients: A comparison of four ancestry groups.

Mohamed ME, Schladt DP, Guan W, Wu B, van Setten J, Keating BJ, Iklé D, Remmel RP, Dorr CR, Mannon RB, Matas AJ, Israni AK, Oetting WS, Jacobson PA; DeKAF Genomics and GEN03 Investigators.

Am J Transplant. 2019 Apr 6. doi: 10.1111/ajt.15385. [Epub ahead of print]

PMID:
30953600
3.

The impact of donor and recipient common clinical and genetic variation on estimated glomerular filtration rate in a European renal transplant population.

Stapleton CP, Heinzel A, Guan W, van der Most PJ, van Setten J, Lord GM, Keating BJ, Israni AK, de Borst MH, Bakker SJL, Snieder H, Weale ME, Delaney F, Hernandez-Fuentes MP, Reindl-Schwaighofer R, Oberbauer R, Jacobson PA, Mark PB, Chapman FA, Phelan PJ, Kennedy C, Sexton D, Murray S, Jardine A, Traynor JP, McKnight AJ, Maxwell AP, Smyth LJ, Oetting WS, Matas AJ, Mannon RB, Schladt DP, Iklé DN, Cavalleri GL, Conlon PJ; UK Ireland Renal Transplant Consortium; DeKAF Genomics and GEN03 Studies; International Genetics and Translational Research in Transplantation Network.

Am J Transplant. 2019 Feb 27. doi: 10.1111/ajt.15326. [Epub ahead of print]

PMID:
30920136
4.

Decision support needs of kidney transplant candidates regarding the deceased donor waiting list: A qualitative study and conceptual framework.

Hart A, Bruin M, Chu S, Matas A, Partin MR, Israni AK.

Clin Transplant. 2019 May;33(5):e13530. doi: 10.1111/ctr.13530. Epub 2019 Apr 1.

PMID:
30865323
5.

How patients choose kidney transplant centers: A qualitative study of patient experiences.

Schaffhausen CR, Bruin MJ, McKinney WT, Snyder JJ, Matas AJ, Kasiske BL, Israni AK.

Clin Transplant. 2019 May;33(5):e13523. doi: 10.1111/ctr.13523. Epub 2019 Apr 21.

PMID:
30861199
6.

The association between loss of Medicare, immunosuppressive medication use, and kidney transplant outcomes.

Hart A, Gustafson SK, Wey A, Salkowski N, Snyder JJ, Kasiske BL, Israni AK.

Am J Transplant. 2019 Jul;19(7):1964-1971. doi: 10.1111/ajt.15293. Epub 2019 Mar 5.

PMID:
30838768
7.

OPTN/SRTR 2017 Annual Data Report: Heart.

Colvin M, Smith JM, Hadley N, Skeans MA, Uccellini K, Lehman R, Robinson AM, Israni AK, Snyder JJ, Kasiske BL.

Am J Transplant. 2019 Feb;19 Suppl 2:323-403. doi: 10.1111/ajt.15278.

PMID:
30811894
8.

OPTN/SRTR 2017 Annual Data Report: Kidney.

Hart A, Smith JM, Skeans MA, Gustafson SK, Wilk AR, Castro S, Robinson A, Wainright JL, Snyder JJ, Kasiske BL, Israni AK.

Am J Transplant. 2019 Feb;19 Suppl 2:19-123. doi: 10.1111/ajt.15274.

PMID:
30811893
9.

OPTN/SRTR 2017 Annual Data Report: Lung.

Valapour M, Lehr CJ, Skeans MA, Smith JM, Uccellini K, Lehman R, Robinson A, Israni AK, Snyder JJ, Kasiske BL.

Am J Transplant. 2019 Feb;19 Suppl 2:404-484. doi: 10.1111/ajt.15279.

PMID:
30811892
10.

OPTN/SRTR 2017 Annual Data Report: Pancreas.

Kandaswamy R, Stock PG, Gustafson SK, Skeans MA, Urban R, Fox A, Odorico JS, Israni AK, Snyder JJ, Kasiske BL.

Am J Transplant. 2019 Feb;19 Suppl 2:124-183. doi: 10.1111/ajt.15275.

PMID:
30811891
11.

OPTN/SRTR 2017 Annual Data Report: Liver.

Kim WR, Lake JR, Smith JM, Schladt DP, Skeans MA, Noreen SM, Robinson AM, Miller E, Snyder JJ, Israni AK, Kasiske BL.

Am J Transplant. 2019 Feb;19 Suppl 2:184-283. doi: 10.1111/ajt.15276.

PMID:
30811890
12.

OPTN/SRTR 2017 Annual Data Report: Intestine.

Smith JM, Weaver T, Skeans MA, Horslen SP, Noreen SM, Snyder JJ, Israni AK, Kasiske BL.

Am J Transplant. 2019 Feb;19 Suppl 2:284-322. doi: 10.1111/ajt.15277.

PMID:
30811888
13.

OPTN/SRTR 2017 Annual Data Report: Deceased Organ Donation.

Israni AK, Zaun D, Rosendale JD, Schaffhausen C, Snyder JJ, Kasiske BL.

Am J Transplant. 2019 Feb;19 Suppl 2:485-516. doi: 10.1111/ajt.15280.

PMID:
30811886
14.

Genetic Variants Associated With Immunosuppressant Pharmacokinetics and Adverse Effects in the DeKAF Genomics Genome-wide Association Studies.

Oetting WS, Wu B, Schladt DP, Guan W, van Setten J, Keating BJ, Iklé D, Remmel RP, Dorr CR, Mannon RB, Matas AJ, Israni AK, Jacobson PA; DeKAF Genomics and GEN-03 Investigators.

Transplantation. 2019 Jun;103(6):1131-1139. doi: 10.1097/TP.0000000000002625.

PMID:
30801552
15.

Analysis of 75 Candidate SNPs Associated with Acute Rejection in Kidney Transplant Recipients: Validation of rs2910164 in MicroRNA MIR146A.

Oetting WS, Schladt DP, Dorr CR, Wu B, Guan W, Remmel RP, Iklé D, Mannon RB, Matas AJ, Israni AK, Jacobson PA; DeKAF Genomics and GEN03 Investigators.

Transplantation. 2019 Feb 11. doi: 10.1097/TP.0000000000002659. [Epub ahead of print]

PMID:
30801535
16.

Impact of Sofosbuvir-Based Therapy on Liver Transplant Candidates with Hepatitis C Virus Infection.

Dellay B, Sexter A, Wang JH, Hess GP, Ray Kim W, Israni AK.

Pharmacotherapy. 2019 Apr;39(4):424-432. doi: 10.1002/phar.2237. Epub 2019 Apr 2.

PMID:
30779203
17.

A systematic review for variables to be collected in a transplant database for improving risk prediction.

Almasri J, Tello M, Benkhadra R, Morrow AS, Hasan B, Farah W, Villalobos NA, Mohammed K, Allen JP, Prokop LJ, Wang Z, Kasiske BL, Israni AK, Murad MH.

Transplantation. 2019 Feb 6. doi: 10.1097/TP.0000000000002652. [Epub ahead of print]

PMID:
30768569
18.

Scientific Registry of Transplant Recipients program-specific reports: where we have been and where we are going.

Kasiske BL, Salkowski N, Wey A, Israni AK, Snyder JJ.

Curr Opin Organ Transplant. 2019 Feb;24(1):58-63. doi: 10.1097/MOT.0000000000000597.

PMID:
30575617
19.

Identification of genetic variants associated with tacrolimus metabolism in kidney transplant recipients by extreme phenotype sampling and next generation sequencing.

Dorr CR, Wu B, Remmel RP, Muthusamy A, Schladt DP, Abrahante JE, Guan W, Mannon RB, Matas AJ, Oetting WS, Jacobson PA, Israni AK; for DeKAF Genomics.

Pharmacogenomics J. 2018 Nov 16. doi: 10.1038/s41397-018-0063-z. [Epub ahead of print]

20.

Urinary microbiome associated with chronic allograft dysfunction in kidney transplant recipients.

Wu JF, Muthusamy A, Al-Ghalith GA, Knights D, Guo B, Wu B, Remmel RP, Schladt DP, Alegre ML, Oetting WS, Jacobson PA, Israni AK.

Clin Transplant. 2018 Dec;32(12):e13436. doi: 10.1111/ctr.13436. Epub 2018 Nov 18.

PMID:
30372560
21.

The importance of transplant program measures: Surveys of three national patient advocacy groups.

Schaffhausen CR, Bruin MJ, Chu S, Wey A, Snyder JJ, Kasiske BL, Israni AK.

Clin Transplant. 2018 Dec;32(12):e13426. doi: 10.1111/ctr.13426. Epub 2018 Oct 31.

PMID:
30326164
22.

Tacrolimus trough and dose intra-patient variability and CYP3A5 genotype: Effects on acute rejection and graft failure in European American and African American kidney transplant recipients.

Seibert SR, Schladt DP, Wu B, Guan W, Dorr C, Remmel RP, Matas AJ, Mannon RB, Israni AK, Oetting WS, Jacobson PA.

Clin Transplant. 2018 Dec;32(12):e13424. doi: 10.1111/ctr.13424. Epub 2018 Oct 31.

PMID:
30318646
23.

The relationship between the C-statistic and the accuracy of program-specific evaluations.

Wey A, Salkowski N, Kasiske BL, Skeans MA, Gustafson SK, Israni AK, Snyder JJ.

Am J Transplant. 2019 Feb;19(2):407-413. doi: 10.1111/ajt.15132. Epub 2018 Oct 29.

PMID:
30282119
24.

Five-tier utility: A start on the path to better reporting, in response to Schold and Buccini.

Wey A, Salkowski N, Kasiske BL, Skeans M, Schaffhausen CR, Gustafson SK, Israni AK, Snyder JJ.

Am J Transplant. 2019 Feb;19(2):608-609. doi: 10.1111/ajt.15120. Epub 2018 Oct 12. No abstract available.

PMID:
30230203
25.

Organ distribution without geographic boundaries: A possible framework for organ allocation.

Snyder JJ, Salkowski N, Wey A, Pyke J, Israni AK, Kasiske BL.

Am J Transplant. 2018 Nov;18(11):2635-2640. doi: 10.1111/ajt.15115. Epub 2018 Sep 29.

PMID:
30203912
26.

Seeking new answers to old questions about public reporting of transplant program performance in the United States.

Kasiske BL, Wey A, Salkowski N, Zaun D, Schaffhausen CR, Israni AK, Snyder JJ.

Am J Transplant. 2019 Feb;19(2):317-323. doi: 10.1111/ajt.15051. Epub 2018 Sep 6.

PMID:
30074680
27.

Comparing Scientific Registry of Transplant Recipients posttransplant program-specific outcome ratings at listing with subsequent recipient outcomes after transplant.

Wey A, Salkowski N, Kasiske BL, Skeans M, Schaffhausen CR, Gustafson SK, Israni AK, Snyder JJ.

Am J Transplant. 2019 Feb;19(2):391-398. doi: 10.1111/ajt.15038. Epub 2018 Aug 31.

PMID:
30053337
28.

Association of pretransplant and posttransplant program ratings with candidate mortality after listing.

Wey A, Gustafson SK, Salkowski N, Kasiske BL, Skeans M, Schaffhausen CR, Israni AK, Snyder JJ.

Am J Transplant. 2019 Feb;19(2):399-406. doi: 10.1111/ajt.15032. Epub 2018 Aug 21.

PMID:
30040191
29.

Heart and lung organ offer acceptance practices of transplant programs are associated with waitlist mortality and organ yield.

Wey A, Valapour M, Skeans MA, Salkowski N, Colvin M, Kasiske BL, Israni AK, Snyder JJ.

Am J Transplant. 2018 Aug;18(8):2061-2067. doi: 10.1111/ajt.14885. Epub 2018 May 9.

PMID:
29673099
30.

NPHP1 (Nephrocystin-1) Gene Deletions Cause Adult-Onset ESRD.

Snoek R, van Setten J, Keating BJ, Israni AK, Jacobson PA, Oetting WS, Matas AJ, Mannon RB, Zhang Z, Zhang W, Hao K, Murphy B, Reindl-Schwaighofer R, Heinzl A, Oberbauer R, Viklicky O, Conlon PJ, Stapleton CP, Bakker SJL, Snieder H, Peters EDJ, van der Zwaag B, Knoers NVAM, de Borst MH, van Eerde AM.

J Am Soc Nephrol. 2018 Jun;29(6):1772-1779. doi: 10.1681/ASN.2017111200. Epub 2018 Apr 13.

31.

Program-specific transplant rate ratios: Association with allocation priority at listing and posttransplant outcomes.

Wey A, Gustafson SK, Salkowski N, Pyke J, Kasiske BL, Israni AK, Snyder JJ.

Am J Transplant. 2018 Jun;18(6):1360-1369. doi: 10.1111/ajt.14684. Epub 2018 Mar 3.

32.

Mycophenolic Acid and Its Metabolites in Kidney Transplant Recipients: A Semimechanistic Enterohepatic Circulation Model to Improve Estimating Exposure.

Okour M, Jacobson PA, Ahmed MA, Israni AK, Brundage RC.

J Clin Pharmacol. 2018 May;58(5):628-639. doi: 10.1002/jcph.1064. Epub 2018 Jan 12.

33.

Attempted validation of 44 reported SNPs associated with tacrolimus troughs in a cohort of kidney allograft recipients.

Oetting WS, Wu B, Schladt DP, Guan W, Remmel RP, Dorr C, Mannon RB, Matas AJ, Israni AK, Jacobson PA.

Pharmacogenomics. 2018 Feb;19(3):175-184. doi: 10.2217/pgs-2017-0187. Epub 2018 Jan 10.

34.

Offer acceptance practices and geographic variability in allocation model for end-stage liver disease at transplant.

Wey A, Pyke J, Schladt DP, Gentry SE, Weaver T, Salkowski N, Kasiske BL, Israni AK, Snyder JJ.

Liver Transpl. 2018 Apr;24(4):478-487. doi: 10.1002/lt.25010. Erratum in: Liver Transpl. 2019 Jun;25(6):974.

35.

Liver Simulated Allocation Modeling: Were the Predictions Accurate for Share 35?

Goel A, Kim WR, Pyke J, Schladt DP, Kasiske BL, Snyder JJ, Lake JR, Israni AK.

Transplantation. 2018 May;102(5):769-774. doi: 10.1097/TP.0000000000002079.

PMID:
29309379
36.

OPTN/SRTR 2016 Annual Data Report: Kidney.

Hart A, Smith JM, Skeans MA, Gustafson SK, Wilk AR, Robinson A, Wainright JL, Haynes CR, Snyder JJ, Kasiske BL, Israni AK.

Am J Transplant. 2018 Jan;18 Suppl 1:18-113. doi: 10.1111/ajt.14557.

37.

OPTN/SRTR 2016 Annual Data Report: Economics.

Schnitzler MA, Skeans MA, Axelrod DA, Lentine KL, Randall HB, Snyder JJ, Israni AK, Kasiske BL.

Am J Transplant. 2018 Jan;18 Suppl 1:464-503. doi: 10.1111/ajt.14564.

38.

OPTN/SRTR 2016 Annual Data Report: Intestine.

Smith JM, Weaver T, Skeans MA, Horslen SP, Harper AM, Snyder JJ, Israni AK, Kasiske BL.

Am J Transplant. 2018 Jan;18 Suppl 1:254-290. doi: 10.1111/ajt.14560.

39.

OPTN/SRTR 2016 Annual Data Report: Pancreas.

Kandaswamy R, Stock PG, Gustafson SK, Skeans MA, Curry MA, Prentice MA, Fox A, Israni AK, Snyder JJ, Kasiske BL.

Am J Transplant. 2018 Jan;18 Suppl 1:114-171. doi: 10.1111/ajt.14558.

40.

OPTN/SRTR 2016 Annual Data Report: Heart.

Colvin M, Smith JM, Hadley N, Skeans MA, Carrico R, Uccellini K, Lehman R, Robinson A, Israni AK, Snyder JJ, Kasiske BL.

Am J Transplant. 2018 Jan;18 Suppl 1:291-362. doi: 10.1111/ajt.14561.

41.

OPTN/SRTR 2016 Annual Data Report: Liver.

Kim WR, Lake JR, Smith JM, Schladt DP, Skeans MA, Harper AM, Wainright JL, Snyder JJ, Israni AK, Kasiske BL.

Am J Transplant. 2018 Jan;18 Suppl 1:172-253. doi: 10.1111/ajt.14559.

42.

OPTN/SRTR 2016 Annual Data Report: Lung.

Valapour M, Lehr CJ, Skeans MA, Smith JM, Carrico R, Uccellini K, Lehman R, Robinson A, Israni AK, Snyder JJ, Kasiske BL.

Am J Transplant. 2018 Jan;18 Suppl 1:363-433. doi: 10.1111/ajt.14562.

43.

OPTN/SRTR 2016 Annual Data Report: Deceased Organ Donation.

Israni AK, Zaun D, Rosendale JD, Schaffhausen C, Snyder JJ, Kasiske BL.

Am J Transplant. 2018 Jan;18 Suppl 1:434-463. doi: 10.1111/ajt.14563.

44.

Genome-wide association study identifies the common variants in CYP3A4 and CYP3A5 responsible for variation in tacrolimus trough concentration in Caucasian kidney transplant recipients.

Oetting WS, Wu B, Schladt DP, Guan W, Remmel RP, Mannon RB, Matas AJ, Israni AK, Jacobson PA.

Pharmacogenomics J. 2018 May 22;18(3):501-505. doi: 10.1038/tpj.2017.49. Epub 2017 Nov 21.

PMID:
29160300
45.

Concepts of Genomics in Kidney Transplantation.

Oetting WS, Dorr C, Remmel RP, Matas AJ, Israni AK, Jacobson PA.

Curr Transplant Rep. 2017 Jun;4(2):116-123. doi: 10.1007/s40472-017-0153-x. Epub 2017 May 24.

46.

Genetics of acute rejection after kidney transplantation.

Dorr CR, Oetting WS, Jacobson PA, Israni AK.

Transpl Int. 2018 Mar;31(3):263-277. doi: 10.1111/tri.13084. Epub 2017 Nov 8. Review.

47.

What patients and members of their support networks ask about transplant program data.

Schaffhausen CR, Bruin MJ, Chesley D, McBride M, Snyder JJ, Kasiske BL, Israni AK.

Clin Transplant. 2017 Dec;31(12). doi: 10.1111/ctr.13125. Epub 2017 Oct 23.

48.

A kidney offer acceptance decision tool to inform the decision to accept an offer or wait for a better kidney.

Wey A, Salkowski N, Kremers WK, Schaffhausen CR, Kasiske BL, Israni AK, Snyder JJ.

Am J Transplant. 2018 Apr;18(4):897-906. doi: 10.1111/ajt.14506. Epub 2017 Oct 17.

49.

Influence of kidney offer acceptance behavior on metrics of allocation efficiency.

Wey A, Salkowski N, Kasiske BL, Israni AK, Snyder JJ.

Clin Transplant. 2017 Sep;31(9). doi: 10.1111/ctr.13057. Epub 2017 Aug 2.

50.

Risk of Second Malignancies in Solid Organ Transplant Recipients Who Develop Keratinocyte Cancers.

Zamoiski RD, Yanik E, Gibson TM, Cahoon EK, Madeleine MM, Lynch CF, Gustafson S, Goodman MT, Skeans M, Israni AK, Engels EA, Morton LM.

Cancer Res. 2017 Aug 1;77(15):4196-4203. doi: 10.1158/0008-5472.CAN-16-3291. Epub 2017 Jun 14.

Supplemental Content

Loading ...
Support Center